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ABSTR AC T

however there is lack of colorectal cancer (CRC) screening
program in South Asia. The purpose of this study is to analyze and review the polyp detection rate (PDR) and ADR and
provide insight into the factors that influence them in Pakistan.
Patients and methods This retrospective, cross-sectional
study was performed at the Aga Khan University Hospital,
Karachi, Pakistan, on patients ≥ 18 years, who underwent
colonoscopy between January 1, 2017 and June 30, 2018.
Results Of 1985 patients, 59 % were male and 41 % female,
with mean age of 47.8 ± 16.2 years. The most common indication for colonoscopy was bleeding-per-rectum (28.0 %)
and overall PDR and ADR were 17.9 % and 9.9 %, respectively. There was no significant difference between genders for
either PDR (P = 0.378) or ADR (P = 0.574). Significantly higher PDR and ADR were found for patients ≥ 50 years (P <
0.001), as well as for suboptimal bowel preparation [PDR
(25.7 %; P = 0.007) and ADR (18.6 %; P = 0.014)]. Interestingly, endoscopists with < 500 colonoscopy-procedural-experience reported a higher PDR (21.6 %; P = 0.020) and ADR
(14.4 %; P = 0.049), corresponding to a significantly higher
PDR (20.6 %; P = 0.005) and ADR (11.7 %; P = 0.02) for endoscopists in practice for ≤ 10 years.
Conclusions We have noticed low PDR and ADR, which require further investigation and research. In addition, we believe there should be a different baseline ADR and PDR as a
quality indicator for colonoscopy in our region, where no
internationally recommended colonoscopic screening programs have been implemented.

Background and study aims Adenoma detection rate
(ADR) is validated for measuring quality of colonoscopy,

Introduction
Colorectal cancer (CRC) is considered the second most common cause for cancer mortality, and is one of the top three
most prevalent cancers worldwide [1]. Screening programs for
CRC have been implemented in many nations because of the
documented association between screening and a sustained reduction in colorectal cancer mortality [2–4]. This benefit is
most likely attributed to surveillance of patients either treated

for CRC or with in whom it is detected early and subsequently
removed endoscopically [5, 6].
The gold standard for CRC screening is colonoscopy, for its
dual role as a diagnostic as well as therapeutic intervention in
detection and removal of adenomas and their premalignant
lesions [7, 8]. However, the effectiveness of colonoscopy is
strongly associated with its quality, which is characterized by
key standard quality indicators (QI) [9]. Among these are cecal
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intubation rate, withdrawal time, quality of bowel preparation,
and adenoma detection rate (ADR).
ADR is most frequently used quality indicator and is now designated as an outcome measure of colonoscopy; it is defined as
the proportion of screening colonoscopies in patients ≥ 50
years, detecting at least one adenoma or adenocarcinoma, and
should ideally be ≥ 25 %. There is compelling evidence to support an inverse correlation between ADR and interval CRC (cancer detected after a screening colonoscopy), which has the potential to lower future mortality from CRC [10]. This is supported by Corley et al, which states that for every 1 % increase in
ADR, there is a 3 % predicted decrease in interval CRC (hazard
ratio 0.97; 95 % Confidence Interval (CI), 0.96–0.98), and a 5 %
decrease in risk of fatal interval CRC (hazard ration 0.95; 95 %
CI, 0.94–0.97) [11]. Although the American Society of Gastrointestinal Endoscopy recommends that colonoscopists report
their ADRs, current evidence suggests low-level detection,
which endangers patients because effective polyp detection
and resection help in CRC prevention [12]. Unfortunately, no
standard CRC screening program exists in Pakistan, and no established measures have been taken to assess the quality of
ADR measurement either.
Our study aimed to focus on and review the ADR of a tertiary
care hospital in Pakistan, to provide insight into the ADR and
quality of colonoscopy, and the factors that affect it, pertinent
to this region of the world.

Patients and methods
We performed a retrospective observational study on patients
aged ≥ 18 years who underwent colonoscopy at the Aga Khan
University Hospital (AKUH), Karachi, between July 1, 2017 to
June 30, 2018. AKUH is a 740-bed private hospital situated in
Karachi and one of the largest tertiary care centers in Pakistan.
Exemption was acquired from the Ethical Review Committee,
and patient data were retrieved using the ICD-10 Coding System.
All colonoscopies were performed by gastroenterologists at
AKUH. Patient preparation consisted of clear liquid diet for 24
hours prior to colonoscopy, and 45 mL of bowel preparation solution, given 6 hours apart. This solution was prepared at the
AKUH Pharmacy and consisted of sodium phosphate monohydrate and sodium phosphate heptahydrate with preservatives.
Patients were consciously sedated by giving 2 to 5 mg midazolam and 2 to 3 mg intravenous nalbuphine. Bowel preparation
was classified into good, suboptimal/reasonable, and poor, on
the basis of the Boston Bowel Preparation Scale (BBPS), which
is a reliable measure of bowel preparation [13], although no
scoring system was assigned. All colonoscopies at AKUH were
performed using the OLYMPUS manufactured EVIS EXERA III
video colonoscopes [CF-H190 L/I (Olympus Corp., Europe) and
CF-HQ190 L/I (Olympus Corp., United States)]. Abnormal findings detected during colonoscopy were biopsied for further
evaluation. Any and all polyps found were removed and biopsied for histopathology.
A predesigned proforma was used to collect variables such
as age, gender, indication of colonoscopy, bowel preparation,
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colonoscopy findings, and histopathology reports. Patients
who underwent sigmoidoscopy only were known cases of familial adenomatous polyposis, or had incomplete data were excluded.
Statistical analyses were carried out using SPSS V25.0, with
continuous data reported as means ± standard deviation (S.D.)
[medians (range)], and categorical variables as gross numbers
and percentages (n; %). Statistical significance of ADR (colonoscopies in which ≥ 1 histologically confirmed adenoma and/or
carcinoma) and PDR (colonoscopies in which ≥ 1 polyp and/or
growth or mass) was calculated using the Chi-squared test for
categorical variables.
P < 0.05 was considered significant for all analyses.

Results
A total of 1985 patients were included in the final sample, of
which 59.0 % (1172) were males and 41.0 % (813) females,
with a mean age of 47.8 ± 16.2 years (48.0, 19–88). The most
common indication for colonoscopy in our patient population
was bleeding-per-rectum [28.0 % (556)], and 94.4 % (1873) of
patients had good bowel-preparations. The most common abnormal finding was hemorrhoids [425 (21.4 %)], with nonspecific colitis as the most frequent finding on histopathology
[498 (25.1 %)]. Polyps were detected in only 12.5 % (248) of colonoscopies, while 5.9 % (118) and 4.0 % (79) adenomas and
carcinomas were found on histopathology, respectively. This
data are presented in further detail in ▶ Table 1. Our overall
PDR and ADR were calculated as 17.9 % (355/1985) and 9.9 %
(197/1985), respectively. Although no significant differences
for either PDR (P = 0.378) or ADR (P = 0.574) were found considering gender, there was a significant greater PDR and ADR in
patients ≥ 50 years (PDR: 24.8 %, P < 0.001; ADR: 15.0 %, P <
0.001). Furthermore, statistically higher PDR (25.7 %; P =
0.007) and ADR (18.6 %; P = 0.014) were found for patients
with suboptimal bowel preparation [3.5 % (70)].
A total of 23 endoscopists performed colonoscopy at AKUH;
we divided them into four groups, based on the number of colonoscopies performed by each endoscopist in the last 10 years
[< 500 (Group 1), 500–999 (Group 2), 1000–1500 (Group 3),
and > 1500 (Group 4)]. Twelve endoscopists were included in
Group 1, five in Group 2, four in Group 3, and two in Group 4.
In our cohort, groups 1, 2, 3 and 4 performed 10.5 % (208),
23.1 % (458), 32.4 % (644) and 34.0 % (675) of the colonoscopies, respectively. Interestingly, the PDR and ADR were found
to be significantly higher for endoscopists in Group 1 (PDR:
21.6 %; P = 0.02 and ADR 14.4 %; P = 0.049).
In addition, we classified endoscopists based on the number
of years of experience; 13 endoscopists had been in practice for
≤ 10 years and 10 had > 10 years of experience. Endoscopists in
practice for ≤ 10 years performed 43.5 % of the colonoscopies
(863) while those with > 10 years’ experience in the field performed the remaining 56.5 % (1122). The PDR and ADR were
found to be significantly higher for endoscopists in practice for
≤ 10 years as compared to those with > 10 years of experience
(PDR: 20.6 % versus 15.8 %, P = 0.005; ADR: 11.7 % versus 8.6 %,
P = 0.02).
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▶ Table 1 Characteristics of Colonoscopy.
Characteristics

Discussion
Total (N = 1985);
n(%)

Indications for colonoscopy
▪ Bleeding per rectum

556 (28.0)

▪ Loose stools

264 (13.3)

▪ Screening

154 (7.8)

▪ Constipation

153 (7.7)

▪ Anemia

152 (7.7)

▪ Altered bowel habits (mixed patterns)

139 (7.0)

▪ Surveillance

136 (6.9)

▪ Abdominal pain

135 (6.8)

▪ Others

296 (14.9)

1

Bowel preparation
▪ Good

1873 (94.4)

▪ Suboptimal

70 (3.5)

▪ Poor

42 (2.1)

Colonoscopy findings
▪ Normal

596 (30.0)

▪ Hemorrhoids

425 (21.4)

▪ Polyp

248 (12.5)

▪ Abnormal growth/mass

107 (5.4)

▪ Colitis/proctitis

315 (15.9)

▪ Diverticulosis
▪ Ulcers (terminal ileum, colonic and rectal)

71 (3.6)
223 (11.2)

Histopathology findings
▪ None (Normal)

1094 (55.1)

▪ Non-specific colitis

498 (25.1)

▪ Adenoma

118 (5.9)

▪ Carcinoma

79 (4.0)

▪ Polyp (hyperplastic/inflammatory/retention)

76 (3.9)

▪ Others 2

71 (3.5)

All categorical variables are reported as numbers (percentages).
1
Indication for colonoscopy: melena, weight loss, inflammatory bowel disease/ crohn’s disease, painful defecation, incontinence, and abnormal CT
scan.
2
Histopathology: infectious colitis, solitary rectal ulcer, melanoma, lymphoma, granulomatous inflammation, lipoma, neuroendocrine tumor and
collagenous colitis.

These results are summarized in ▶ Table 2.

Our focused study aimed to provide insight into the quality of
colonoscopies performed in a part of the world where no routine colonoscopy screening program is available. We report a
PDR and ADR of 17.9 % and 9.9 %, respectively. Our PDR seems
to be lower compared to Western populations, as demonstrated by Cooper et al., which reported a PDR of 23.9 % to 35.7 %
[14]. This variation might suggest a lower population incidence
of polyps or is a result of poor practices due to lack of a stringent criteria to follow QI in colonoscopy, as well as poor knowledge about the importance of these validated QI. Our lower
PDR is supported by regional studies from Rehman et al. and
Saleh et al., which report a PDR of 11.3 % (57/505), and 7.9 %
(28/354), respectively [15, 16]. However, certain limitations
such as a smaller sample size, and sub-standard cecal intubation rate of Rehman et al., might have contributed to missed lesions and overlooked positive detection within samples. Furthermore, no reports of ADR were present in either article, preventing us from conclusively inferring on the PDR and ADR of
our population.
In addition, the lower ADR and PDR of our population may be
due to a younger presenting age of patients, i. e. 47.8 ± 16.2
years. Although this supports decreasing the minimum recommended age of colonoscopy screening from 50 to 45 [17], it is
lower than the age after which most people undergo screening
colonoscopy for CRC [18]; this can contribute to missed diagnoses within our broad population. Both ADR and PDR were significantly higher in our patients ≥ 50 years (P < 0.001), supporting
that increasing age is a predictor of adenoma at colonoscopy
[19].
Our study does not report a significant predominance of
polyps based on gender (P = 0.378), contradicting reports from
Cooper et al. which showed that PDR was higher in males (P <
0.0001). Lee and colleagues from the United Kingdom found
their ADR to be 46.5 %, which was similarly increased in the elderly (age > 65) (P < 0.001), but comparatively higher in men
(52.9 %) than in women (36.5 %) (P < 0.001) [20], signifying the
difference in results from our population. We are unable to conclude any biological plausibility for this difference in gender,
warranting a more detailed look into the subjects themselves.
Another factor that affects the quality of colonoscopy,
hence the ADR, is bowel preparation; it has been reported that
approximately 20 % to 25 % of all colonoscopies are in patients
who have poor or inadequate bowel preparation, leading to
multiple adverse events, including a lower ADR [21, 22]. While
94.4 % of our colonoscopy preparations were good, the remaining 5.6 % were either suboptimal or poor, as result of decreased
patient compliance, failure to comprehend and follow through
with the instructions provided. It is interesting to note, however, that a higher ADR (P = 0.014) and PDR (25.7 %; P = 0.007)
were found for suboptimal bowel preparation. This association
has been found in only a handful of other studies, and multiple
reasons have been hypothesized for an explanation; residual
stool in a suboptimal bowel preparation may attach to mucus
caps of serrated polyps, allowing for better visualization. Additional washing by the endoscopist results in a higher attention
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▶ Table 2 Distribution of PDR and ADR.
Variables

Total (N = 1985)

PDR (N = 355); n (%)

P value (PDR)

ADR (N = 197); n (%)

P value (ADR)

▪ Age (years) ± S.D.

47.8 ± 16.2

–

–

–

–

▪ Median age (range)

48.0 (19–88)

0.378

120 (10.2)

0.574

Gender
▪ Male

1172 (59.0)

217 (18.5)

▪ Female

813 (41.0)

138 (17.0)

▪ ≥ 50

934 (47.1)

232 (24.8)

▪ < 50

1051 (52.9)

123 (11.7)

▪ Good

1873 (94.4)

336 (17.9)

▪ Suboptimal

70 (3.5)

18 (25.7)

13 (18.6)

▪ Poor

42 (2.1)

1 (2.4)

1 (2.4)

77 (9.5)

Age (years)
< 0.001 1

140 (15.0)

< 0.001 1

57 (5.4)

Bowel preparation
0.007 1

183 (9.8)

0.014 1

Endoscopist procedural experience (10 years)
▪ < 500

208 (10.5)

45 (21.6)

▪ 500–999

458 (23.1)

63 (13.8)

41 (9.0)

▪ 1000–1500

644 (32.4)

111 (17.2)

53 (8.2)

▪ > 1500

675 (34.0)

136 (20.1)

73 (10.8)

▪ ≤ 10

863 (43.5)

178 (20.6)

▪ > 10

1122 (56.5)

177 (15.8)

0.020 1

30 (14.4)

0.049 1

Endoscopist experience (years)
0.005 1

101 (11.7)

0.020 1

96 (8.6)

All categorical variables are reported as numbers (percentages), and continuous variables as Means ± S.D. and Median (range). Chi-squared test was used for categorical variables.
PDR, polyp detection rate; ADR, adenoma detection rate.
1
P values are significant ( < 0.05).

to mucosa, subsequently increasing incidental PDR. Moreover,
an excellent preparation may falsely increase confidence of the
endoscopist, resulting a decreased quality of inspection [23–
25].
Multiple previous studies have documented an association
of higher PDR and ADR with greater experience of endoscopists. Pace et al. reported increased rates of polyp and adenoma detection with high annual case volumes (> 530) (P <
0.001) [26], while another study found more experienced
endoscopists were able to detect a higher number of smallersized polyps (< 3 mm), as well as adenomas with advanced histology (P < 0.0001) [27]. Hence, the most surprising difference
is that our study showed that endoscopists with experience
performing < 500 colonoscopies, had a statistically significant
higher PDR (21.6 %; P = 0.02) and ADR (14.4 %; P = 0.049) as
compared to those with experience with > 500 procedures, corresponding to a significantly higher PDR (20.6 %; P = 0.005) and
ADR (11.7 %; P = 0.02) for endoscopists in practice for ≤ 10
years. This disparity may be attributed to a higher-volume patient load and efficiency demands for more experienced endoscopists, resulting in a shorter withdrawal time and less meticu-
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lous examination [28]. Furthermore, endoscopists with less experience are expected to perform a more extensive examination during their training and practice, and hence, they have a
greater incidental finding rate. Endoscopist fatigue also should
be taken into consideration, since a significant association has
been documented between progress of the day/endoscopy
shift and reduced PDR [29–31]. As there is contradictory evidence for this postulation [32, 33], further investigations to define, measure, and identify factors related to endoscopist fatigue are greatly needed.
Our study has several limitations. Because it was a singlecenter study, the results are limited by external validity. In addition, no numerical or objective documentation about bowel
preparation on the BBPS was performed; thus, we recommend
modifying regional institutional practices to include such an
objective outcome when assessing quality of bowel preparation. We were also unable to quantify the number of continuing-medical-education (CME) meetings attended by our endoscopists. These hands-on educational sessions can increase understanding of polyp morphology and examination techniques,
which subsequently results in better colonoscopy performance
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with a higher ADR. This is supported by a report by Adler et al.,
which showed that the number of CME meetings attended (P =
0.012) as well as colonoscopy scope generation (P = 0.001)
accounted for approximately 40 % of the inter-physician variability for ADR [34]. We consider the generation of instruments
used as a strength of our study because the latest generation of
wide-angle, high-definition colonoscopes can improve ADR by
22 %, as compared with mixed, older endoscopes [35].

Conclusions
In summary, we report low PDR and ADR, although multifactorial causes may be implicated as discussed above. We strongly
urge implementation of a regional screening colonoscopy program and notification of endoscopists about their ADRs and
their importance as a quality indicator for colonoscopy. Although our data can be used to provide a baseline for comparison by other regional endoscopists, future multicenter, prospective studies need to be conducted to generate conclusive
evidence and establish a baseline PDR and ADR. Further research must be undertaken to evaluate other quality indicators,
as a step towards improvement of the overall quality of colonoscopies performed.
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